Search tips
Search criteria 


Logo of envhperEnvironmental Health PerspectivesBrowse ArticlesAbout EHPGeneral InformationAuthorsMediaProgramsPartnerships
Environ Health Perspect. 1993 October; 101(5): 372–377.
PMCID: PMC1519851
Research Article

Medical hypothesis: xenoestrogens as preventable causes of breast cancer.


Changes in documented risk factors for breast cancer and rates of screening cannot completely explain recent increases in incidence or mortality. Established risk factors for breast cancer, including genetics, account for at best 30% of cases. Most of these risk factors can be linked to total lifetime exposure to bioavailable estrogens. Experimental evidence reveals that compounds such as some chlorinated organics, polycyclic aromatic hydrocarbons (PAHs), triazine herbicides, and pharmaceuticals affect estrogen production and metabolism and thus function as xenoestrogens. Many of these xenoestrogenic compounds also experimentally induce mammary carcinogenesis. Recent epidemiologic studies have found that breast fat and serum lipids of women with breast cancer contain significantly elevated levels of some chlorinated organics compared with noncancer controls. As the proportion of inherited breast cancer in the population is small, most breast cancers are due to acquired mutations. Thus, the induction of breast cancer in the majority of cases stems from interactions between host factors, including genetics and environmental carcinogens. We hypothesize that substances such as xenoestrogens increase the risk of breast cancer by mechanisms which include interaction with breast-cancer susceptibility genes. A series of major epidemiologic studies need to be developed to evaluate this hypothesis, including studies of estrogen metabolism, the role of specific xenoestrogenic substances in breast cancer, and relevant genetic-environmental interactions. In addition, experimental studies are needed to evaluate biologic markers of suspect xenoestrogens and biologic markers of host susceptibility and identify pathways of estrogenicity that affect the development of breast cancer. If xenoestrogens do play a role in breast cancer, reductions in exposure will provide an opportunity for primary prevention of this growing disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention of cancer in women. Science. 1993 Jan 29;259(5095):633–638. [PubMed]
  • Feuer EJ, Wun LM. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol. 1992 Dec 15;136(12):1423–1436. [PubMed]
  • Hahn RA, Moolgavkar SH. Nulliparity, decade of first birth, and breast cancer in Connecticut cohorts, 1855 to 1945: an ecological study. Am J Public Health. 1989 Nov;79(11):1503–1507. [PubMed]
  • Hoel DG, Davis DL, Miller AB, Sondik EJ, Swerdlow AJ. Trends in cancer mortality in 15 industrialized countries, 1969-1986. J Natl Cancer Inst. 1992 Mar 4;84(5):313–320. [PubMed]
  • Kohlmeier L, Rehm J, Hoffmeister H. Lifestyle and trends in worldwide breast cancer rates. Ann N Y Acad Sci. 1990;609:259–268. [PubMed]
  • Henderson BE, Ross RK, Pike MC. Toward the primary prevention of cancer. Science. 1991 Nov 22;254(5035):1131–1138. [PubMed]
  • Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988 Jan;24(1):29–43. [PubMed]
  • Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. 1985 Aug;45(8):3415–3443. [PubMed]
  • Bradley CJ, Kledzik GS, Meites J. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development. Cancer Res. 1976 Feb;36(2 Pt 1):319–324. [PubMed]
  • Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst. 1992 Apr 15;84(8):634–638. [PubMed]
  • Bradlow HL, Michnovicz J, Telang NT, Osborne MP. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis. 1991 Sep;12(9):1571–1574. [PubMed]
  • Westin JB, Richter E. The Israeli breast-cancer anomaly. Ann N Y Acad Sci. 1990;609:269–279. [PubMed]
  • Fishman J, Bradlow HL. Effect of malnutrition on the metabolism of sex hormones in man. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 2):721–728. [PubMed]
  • Soto AM, Sonnenschein C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem. 1985 Jul;23(1):87–94. [PubMed]
  • Spicer DV, Pike MC, Henderson BE. Ovarian cancer and long-term tamoxifen in premenopausal women. Lancet. 1991 Jun 8;337(8754):1414–1414. [PubMed]
  • Galbraith RA, Michnovicz JJ. The effects of cimetidine on the oxidative metabolism of estradiol. N Engl J Med. 1989 Aug 3;321(5):269–274. [PubMed]
  • Porter WP, Hinsdill R, Fairbrother A, Olson LJ, Jaeger J, Yuill T, Bisgaard S, Hunter WG, Nolan K. Toxicant-disease-environment interactions associated with suppression of immune system, growth, and reproduction. Science. 1984 Jun 1;224(4652):1014–1017. [PubMed]
  • Bartley J, Bartholomew JC, Stampfer MR. Metabolism of benzo(a)pyrene by human epithelial and fibroblastic cells: metabolite patterns and DNA adduct formation. J Cell Biochem. 1982;18(2):135–148. [PubMed]
  • Khan SU, Foster TS. Residues of atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine)and its metabolities in chicken tissues. J Agric Food Chem. 1976 Jul-Aug;24(4):768–771. [PubMed]
  • Pintér A, Török G, Börzsönyi M, Surján A, Csík M, Kelecsényi Z, Kocsis Z. Long-term carcinogenicity bioassay of the herbicide atrazine in F344 rats. Neoplasma. 1990;37(5):533–544. [PubMed]
  • Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet. 1992 Oct 24;340(8826):1015–1018. [PubMed]
  • Hsieh CC, Lan SJ, Ekbom A, Petridou E, Adami HO, Trichopoulos D. Twin membership and breast cancer risk. Am J Epidemiol. 1992 Dec 1;136(11):1321–1326. [PubMed]
  • Trichopoulos D, Brown J, MacMahon B. Urine estrogens and breast cancer risk factors among post-menopausal women. Int J Cancer. 1987 Dec 15;40(6):721–725. [PubMed]
  • Harris JR, Lippman ME, Veronesi U, Willett W. Breast cancer (1) N Engl J Med. 1992 Jul 30;327(5):319–328. [PubMed]
  • Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsouyanni K, Lubin F, Marubini E, Modan B, Rohan T, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990 Apr 4;82(7):561–569. [PubMed]
  • Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. Dietary fat and the risk of breast cancer. N Engl J Med. 1987 Jan 1;316(1):22–28. [PubMed]
  • Manz A, Berger J, Dwyer JH, Flesch-Janys D, Nagel S, Waltsgott H. Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet. 1991 Oct 19;338(8773):959–964. [PubMed]
  • Kuratsune M, Ikeda M, Nakamura Y, Hirohata T. A cohort study on mortality of "yusho" patients: a preliminary report. Princess Takamatsu Symp. 1987;18:61–66. [PubMed]
  • Bertazzi PA, Zocchetti C, Pesatori AC, Guercilena S, Sanarico M, Radice L. Ten-year mortality study of the population involved in the Seveso incident in 1976. Am J Epidemiol. 1989 Jun;129(6):1187–1200. [PubMed]
  • Dusich K, Sigurdson E, Hall WN, Dean AG. Cancer rates in a community exposed to low levels of creosote components in municipal water. Minn Med. 1980 Nov;63(11):803–806. [PubMed]
  • Dean AG, Imrey HH, Dusich K, Hall WN. Adjusting morbidity ratios in two communities using risk factor prevalence in cases. Am J Epidemiol. 1988 Mar;127(3):654–662. [PubMed]
  • Hall NE, Rosenman KD. Cancer by industry: analysis of a population-based cancer registry with an emphasis on blue-collar workers. Am J Ind Med. 1991;19(2):145–159. [PubMed]
  • Griffith J, Duncan RC, Riggan WB, Pellom AC. Cancer mortality in U.S. counties with hazardous waste sites and ground water pollution. Arch Environ Health. 1989 Mar-Apr;44(2):69–74. [PubMed]
  • Unger M, Kiaer H, Blichert-Toft M, Olsen J, Clausen J. Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res. 1984 Jun;34(1):24–28. [PubMed]
  • Falck F, Jr, Ricci A, Jr, Wolff MS, Godbold J, Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health. 1992 Mar-Apr;47(2):143–146. [PubMed]
  • Mussalo-Rauhamaa H, Häsänen E, Pyysalo H, Antervo K, Kauppila R, Pantzar P. Occurrence of beta-hexachlorocyclohexane in breast cancer patients. Cancer. 1990 Nov 15;66(10):2124–2128. [PubMed]
  • Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst. 1993 Apr 21;85(8):648–652. [PubMed]
  • Donna A, Betta PG, Robutti F, Crosignani P, Berrino F, Bellingeri D. Ovarian mesothelial tumors and herbicides: a case-control study. Carcinogenesis. 1984 Jul;5(7):941–942. [PubMed]
  • Donna A, Crosignani P, Robutti F, Betta PG, Bocca R, Mariani N, Ferrario F, Fissi R, Berrino F. Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health. 1989 Feb;15(1):47–53. [PubMed]
  • Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet. 1991 Feb;48(2):232–242. [PubMed]
  • Li FP, Fraumeni JF., Jr Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969 Oct;71(4):747–752. [PubMed]
  • Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, Lenoir GM. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet. 1991 Jul 13;338(8759):82–83. [PubMed]
  • Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990 Dec 20;348(6303):747–749. [PubMed]
  • King MC. Breast cancer genes: how many, where and who are they? Nat Genet. 1992 Oct;2(2):89–90. [PubMed]
  • Law JC, Strong LC, Chidambaram A, Ferrell RE. A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res. 1991 Dec 1;51(23 Pt 1):6385–6387. [PubMed]
  • Ponder B. Cancer. Gene losses in human tumours. Nature. 1988 Sep 29;335(6189):400–402. [PubMed]
  • Smith SA, Easton DF, Evans DG, Ponder BA. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet. 1992 Oct;2(2):128–131. [PubMed]
  • Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990 Dec 21;250(4988):1684–1689. [PubMed]
  • Holm LE, Nordevang E, Hjalmar ML, Lidbrink E, Callmer E, Nilsson B. Treatment failure and dietary habits in women with breast cancer. J Natl Cancer Inst. 1993 Jan 6;85(1):32–36. [PubMed]
  • Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 1993 May 29;341(8857):1392–1395. [PubMed]
  • Giwercman A, Skakkebaek NE. The human testis--an organ at risk? Int J Androl. 1992 Oct;15(5):373–375. [PubMed]
  • Johnson DC, Sen M, Dey SK. Differential effects of dichlorodiphenyltrichloroethane analogs, chlordecone, and 2,3,7,8-tetrachlorodibenzo-p-dioxin on establishment of pregnancy in the hypophysectomized rat. Proc Soc Exp Biol Med. 1992 Jan;199(1):42–48. [PubMed]
  • Nelson JA. Effects of dichlorodiphenyltrichloroethane (DDT) analogs and polychlorinated biphenyl (PCB) mixtures on 17beta-(3H)estradiol binding to rat uterine receptor. Biochem Pharmacol. 1974 Jan 15;23(2):447–451. [PubMed]
  • Welch RM, Levin W, Conney AH. Estrogenic action of DDT and its analogs. Toxicol Appl Pharmacol. 1969 Mar;14(2):358–367. [PubMed]
  • Coosen R, van Velsen FL. Effects of the beta-isomer of hexachlorocyclohexane on estrogen-sensitive human mammary tumor cells. Toxicol Appl Pharmacol. 1989 Nov;101(2):310–318. [PubMed]
  • Korach KS, Sarver P, Chae K, McLachlan JA, McKinney JD. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes. Mol Pharmacol. 1988 Jan;33(1):120–126. [PubMed]
  • Ghinea E, Dumitriu L, Stefanovici G, Pop A, Damian A, Handoca A, Stanciu R. Protein content and thyroid hormone release in vitro by differentiated thyroid cancer cells in the presence of estradiol, dehydroepiandrosterone, polypeptidic hormones and pesticides. Endocrinologie. 1988 Jul-Sep;26(3):165–171. [PubMed]
  • Maltoni C, Ciliberti A, Cotti G, Conti B, Belpoggi F. Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology. Environ Health Perspect. 1989 Jul;82:109–124. [PMC free article] [PubMed]
  • HUGGINS C, YANG NC. Induction and extinction of mammary cancer. A striking effect of hydrocarbons permits analysis of mechanisms of causes and cure of breast cancer. Science. 1962 Jul 27;137(3526):257–262. [PubMed]
  • SNELL KC, STEWART HL. Pulmonary adenomatosis induced in DBA/2 mice by oral administration of dibenz[a,h]-anthracene. J Natl Cancer Inst. 1962 May;28:1043–1051. [PubMed]
  • Wassermann M, Nogueira DP, Tomatis L, Mirra AP, Shibata H, Arie G, Cucos S, Wassermann D. Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol. 1976 Apr;15(4):478–484. [PubMed]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Science